Ingredion (NYSE:INGR) Price Target Raised to $108.00 at UBS Group

Ingredion (NYSE:INGR) had its price target lifted by UBS Group from $104.00 to $108.00 in a research note issued on Wednesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s price target suggests a potential upside of 4.52% from the company’s previous close.

INGR has been the topic of several other reports. Barclays dropped their target price on Ingredion from $120.00 to $118.00 and set an “equal weight” rating on the stock in a research report on Wednesday. Zacks Research upgraded shares of Ingredion from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 14th. Benchmark reaffirmed a “buy” rating on shares of Ingredion in a research note on Tuesday, June 9th. Oppenheimer cut shares of Ingredion from an “outperform” rating to a “market perform” rating in a report on Monday, June 8th. Finally, Weiss Ratings downgraded shares of Ingredion from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, July 8th. One investment analyst has rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $121.29.

Ingredion Trading Down 1.2%

Ingredion stock traded down $1.30 during midday trading on Wednesday, reaching $103.33. The stock had a trading volume of 887,407 shares, compared to its average volume of 749,863. The firm’s fifty day simple moving average is $99.95 and its two-hundred day simple moving average is $108.31. The firm has a market cap of $6.52 billion, a price-to-earnings ratio of 9.95, a PEG ratio of 0.84 and a beta of 0.62. Ingredion has a twelve month low of $94.44 and a twelve month high of $130.48. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.76 and a quick ratio of 1.83.

Ingredion (NYSE:INGR) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $2.82 earnings per share for the quarter, beating the consensus estimate of $2.71 by $0.11. Ingredion had a return on equity of 15.86% and a net margin of 9.36%.The firm had revenue of $1.85 billion for the quarter, compared to analyst estimates of $1.83 billion. During the same period in the previous year, the firm earned $2.87 earnings per share. Ingredion’s quarterly revenue was up .9% on a year-over-year basis. Ingredion has set its FY 2026 guidance at 10.300-10.900 EPS. Equities analysts anticipate that Ingredion will post 10.81 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in INGR. Fifth Third Wealth Advisors LLC lifted its holdings in shares of Ingredion by 4.1% during the first quarter. Fifth Third Wealth Advisors LLC now owns 2,221 shares of the company’s stock worth $250,000 after buying an additional 88 shares during the last quarter. Vista Investment Management increased its position in Ingredion by 0.8% during the second quarter. Vista Investment Management now owns 10,789 shares of the company’s stock worth $1,463,000 after acquiring an additional 89 shares during the period. PNC Financial Services Group Inc. increased its position in Ingredion by 0.4% during the fourth quarter. PNC Financial Services Group Inc. now owns 25,293 shares of the company’s stock worth $2,789,000 after acquiring an additional 91 shares during the period. Teza Capital Management LLC raised its stake in Ingredion by 4.2% during the 2nd quarter. Teza Capital Management LLC now owns 2,275 shares of the company’s stock valued at $309,000 after purchasing an additional 92 shares during the last quarter. Finally, Murphy Pohlad Asset Management LLC raised its stake in Ingredion by 1.2% during the 4th quarter. Murphy Pohlad Asset Management LLC now owns 8,340 shares of the company’s stock valued at $920,000 after purchasing an additional 95 shares during the last quarter. 85.27% of the stock is owned by institutional investors.

Key Stories Impacting Ingredion

Here are the key news stories impacting Ingredion this week:

• Positive Sentiment: Ingredion reported second-quarter adjusted EPS of $2.82, above the roughly $2.71–$2.73 analyst consensus, while revenue of $1.85 billion also exceeded estimates near $1.83 billion. Ingredion Q2 Earnings and Revenues Beat Estimates
• Positive Sentiment: Texture & Healthful Solutions was a key growth area: volume increased 7% and segment sales rose 5% to $627 million, with foreign-exchange gains helping offset other headwinds. Ingredion Q2 Earnings Beat Estimates on T&HS Volume Growth
• Positive Sentiment: Shareholders accepted Ingredion’s 595-pence all-cash offer for Tate & Lyle. Management expects the transaction to generate approximately $130 million in annual run-rate synergies by 2030, potentially supporting longer-term earnings growth. Ingredion Tate & Lyle Deal and Guidance
• Neutral Sentiment: Ingredion reaffirmed its amended 2026 guidance for reported EPS of $9.15–$9.75 and adjusted EPS of $10.30–$10.90, broadly consistent with analyst expectations but implying limited near-term upside without stronger operating performance.
• Negative Sentiment: Underlying profitability weakened. Reported EPS fell to $1.78 from $2.99, reported operating income declined 31% to $188 million, and adjusted operating income fell 5% to $258 million. Higher costs, supply-chain disruptions and issues affecting the Argo business offset the adjusted earnings beat. Ingredion Second Quarter 2026 Results
• Negative Sentiment: Food & Industrial Ingredients sales in the U.S. and Canada dropped 7% to $488 million, highlighting uneven demand across the portfolio. Recent insider activity also showed sales and no purchases, which may add to investor caution.

About Ingredion

Ingredion Incorporated is a global ingredient solutions company specializing in the production and sale of starches, sweeteners, nutrition ingredients and biomaterials derived primarily from corn and other plant-based raw materials. The company serves a diverse set of industries, including food and beverage, brewing, pharmaceuticals and personal care, providing functional ingredients that enhance texture, stability, flavor and nutritional value in a wide array of end products.

The company’s product portfolio comprises native and modified starches, high-fructose corn syrup, dextrose, maltodextrins, specialty sweeteners and various texturizers.